Atlas Trials

MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer

Clinical trial NCT05108740 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT05108740
Sponsor
Novartis Pharmaceuticals
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Advanced Hormone Receptor Positive (HR+) Breast Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.